Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation

被引:1
作者
Black-Maier, Eric [1 ]
Lewis, Robert K. [1 ]
Rehorn, Michael [1 ]
Loungani, Rahul [1 ]
Friedman, Daniel J. [2 ]
Frazier-Mills, Camille [1 ]
Jackson, Kevin P. [1 ]
Atwater, Brett D. [1 ]
Milano, Carmelo A. [3 ]
Schroder, Jacob N. [3 ]
Pokorney, Sean D. [1 ]
Piccini, Jonathan P. [1 ]
机构
[1] Duke Univ, Med Ctr, Div Cardiol, Durham, NC USA
[2] Yale Univ, Sch Med, Div Electrophysiol, New Haven, CT USA
[3] Duke Univ, Med Ctr, Div Cardiothorac Surg, Durham, NC USA
关键词
implantable cardioverter-defibrillator; lead dysfunction; lead revision; left ventricular assist device;
D O I
10.1111/jce.14487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Lead dysfunction can lead to serious consequences including failure to treat ventricular tachycardia or fibrillation (VT/VF). The incidence and mechanisms of lead dysfunction following left ventricular assist device (LVAD) implantation are not well-described. We sought to determine the incidence, mechanisms, timing, and complications of right ventricular lead dysfunction requiring revision following LVAD implantation. Methods Retrospective observational chart review of all LVAD recipients with pre-existing implantable cardioverter-defibrillator (ICD) from 2009 to 2018 was performed including device interrogation reports, laboratory and imaging data, procedural reports, and clinical outcomes. Results Among 583 patients with an ICD in situ undergoing LVAD implant, the median (interquartile range) age was 62.5 (15.7) years, 21% were female, and the types of LVADs included HeartWare HVAD (26%), HeartMate II (52%), and HeartMate III (22%). Right ventricular lead revision was performed in 38 patients (6.5%) at a median (25th, 75th) of 16.4 (3.6, 29.2) months following LVAD. Mechanisms of lead dysfunction included macrodislodgement (n = 4), surgical lead injury (n = 4), recall (n = 3), insulation failure (n = 8) or conductor fracture (n = 7), and alterations in the lead-myocardial interface (n = 12). Undersensing requiring revision occurred in 22 (58%) cases. Clinical sequelae of undersensing included failure to detect VT/VF (n = 4) and pacing-induced torsade de pointes (n = 1). Oversensing occurred in 12 (32%) and sequelae included inappropriate antitachycardia pacing ([ATP], n = 8), inappropriate ICD shock (n = 6), and ATP-induced VT (n = 1). Conclusion The incidence of right ventricular lead dysfunction following LVAD implantation is significant and has important clinical sequelae. Physicians should remain vigilant for lead dysfunction after LVAD surgery and test lead function before discharge.
引用
收藏
页码:1509 / 1518
页数:10
相关论文
共 50 条
[41]   Improvement of left ventricular function with surgical revascularization in patients eligible for implantable cardioverter-defibrillator [J].
Adabag, Selcuk ;
Carlson, Selma ;
Gravely, Amy ;
Buelt-Gebhardt, Melissa ;
Madjid, Mohammad ;
Naksuk, Niyada .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2022, 33 (02) :244-251
[42]   Development of the Implantable Cardioverter-Defibrillator [J].
Maron, Barry J. ;
Estes, N. A. Mark ;
Rowin, Ethan J. ;
Maron, Martin S. ;
Reynolds, Matthew R. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (04) :353-373
[43]   The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure [J].
Al-Majed, Nawaf S. ;
Ezekowitz, Justin A. .
CURRENT CARDIOLOGY REPORTS, 2012, 14 (03) :299-307
[44]   CONSISTENT SUBCUTANEOUS PREPECTORAL IMPLANTATION OF A NEW IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR [J].
STANTON, MS ;
HAYES, DL ;
MUNGER, TM ;
TRUSTY, JM ;
ESPINOSA, RE ;
SHEN, WK ;
OSBORN, MJ ;
PACKER, DL ;
HAMMILL, SC .
MAYO CLINIC PROCEEDINGS, 1994, 69 (04) :309-314
[45]   The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure [J].
Nawaf S. Al-Majed ;
Justin A. Ezekowitz .
Current Cardiology Reports, 2012, 14 :299-307
[46]   Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis [J].
Koman, Eduard ;
Gupta, Ashwani ;
Subzposh, Faiz ;
Saltzman, Heath ;
Kutalek, Steven P. .
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2016, 45 (02) :219-223
[47]   Left ventricular sphericity index analysis for the prediction of appropriate implantable cardioverter-defibrillator therapy [J].
Anvari, Shideh ;
Akbarzadeh, Mohammad Ali ;
Bayat, Fariba ;
Namazi, Mohammad Hasan ;
Safi, Morteza .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2018, 41 (09) :1192-1196
[48]   Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator [J].
Uslu, Abdulkadir ;
Dogan, Cem ;
Duman, Hakan ;
Tanboga, Ibrahim Halil ;
Askin, Lutfu ;
Sevimli, Serdar .
NORTHERN CLINICS OF ISTANBUL, 2019, 6 (01) :40-47
[49]   Twiddling with an implantable cardioverter-defibrillator [J].
McCann, Conor J. ;
Beelen, Roel ;
Geelen, Peter .
ACTA CARDIOLOGICA, 2009, 64 (05) :695-695
[50]   Implantable Cardioverter-Defibrillator Implantation, Continuation, and Deactivation in Elderly Patients [J].
Schleifer J.W. ;
Shen W.-K. .
Current Geriatrics Reports, 2017, 6 (4) :279-289